Management of acute myelogenous leukemia in the elderly. Cancer Control 2003; 10: 469-477.Rathnasabapathy R, Lancet JE. Management of acute myelogenous leukemia in the elderly. Can- cer Control. 2003;10:469-477.Rathnasabapathy R, Lancet JE. Management of acute myelogenous leukemia in...
(1965), Management of the acute leukemia patient and family. CA: A Cancer Journal for Clinicians, 15: 14–17. doi: 10.3322/canjclin.15.1.14 Author Information Professor of Pathology, Harvard Medical School, at The Children's Hospital and Director of Research, The Children's Cancer Research ...
childhood cases appear to be lymphocytic disease in which one class of leukocytes be (lymphogenous) leukemia, 10 per cent neu trophil granulocytic (myelogenous, myelo comes anarchistic and proliferates irreversibly cytic ), 2 per cent monocytic, and 3 per cent until the death of the patient....
Treatment of Acute Myeloid Leukemia During Pregnancy Systematically review the literature assessing outcomes of acute myeloid leukemia (AML) treatment during pregnancy.A Pubmed literature search (January 1969... Abraham,Chang,Samit,... - 《Annals of Pharmacotherapy》 被引量: 15发表: 2014年 Diagnosis...
Introduction: Febrile neutropenia represents one of the most common treatment-associated complications in the management of acute myeloid leukemia (AML) and is considered an oncologic emergency. Rapid and detailed workup as well as the initiation of empiric broad-spectrum antibiotic therapy is critical ...
p63 is frequently used to confirm a diagnosis of adenocarcinoma of the lung. Explain the role of these markers in terms of differential expression, specificity, and overall contribution to diagnosis. What do these following diseases have in common? Chronic Lymphocytic Leukemia ...
Current and emerging strategies for the management of acute myeloid leukemia in the elderly Acute myeloid leukemia(AML) accounts for approximately 80% of acute leukemias diagnosed in adults.As 35% of newly diagnosed patients are aged鈮 75 and the m... J Laubach,AV Rao - 《Chinese Clinical On...
Intensive remission chemotherapy followed by post-remission consolidation and maintenance therapies has achieved complete remission rates of 75% to 90% and 3-year survival rates of 25% to 50% in adults with acute lymphoblastic leukemia (ALL). These results, although promising, are still less favorab...
doi:10.1016/0145-2126(93)90032-GJanLihemarkSDOSLeukemia Research
Other risks include disease relapse (35%-41%) and the development of acute myeloid leukemia or of myelodysplastic syndrome (10%-15% at 10 years).[20,22,24] Paroxysmal nocturnal hemoglobinuria can also occur as a late complication of aplastic anemia. Recently, high-dose cyclophosphamide without ...